Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ferslew, BC"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology; May2017, Vol. 6 Issue 5, p331-339, 9p
Autor:
Ferslew, BC, Johnston, CK, Tsakalozou, E, Bridges, AS, Paine, MF, Jia, W, Stewart, PW, Barritt, AS, Brouwer, KLR
Publikováno v:
Clinical Pharmacology & Therapeutics; Apr2015, Vol. 97 Issue 4, p419-427, 9p
Autor:
Ferslew BC; Astellas Pharma Global Development Inc., Northbrook, Illinois, USA., Smulders R; Astellas Pharma Global Development Inc., Northbrook, Illinois, USA., Zhu T; Astellas Pharma Global Development Inc., Northbrook, Illinois, USA., Blauwet MB; Astellas Pharma Global Development Inc., Northbrook, Illinois, USA., Kusawake T; Astellas Pharma Inc., Tokyo, Japan., Spence A; Astellas Pharma Global Development Inc., Northbrook, Illinois, USA., Aldridge K; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., DeBerg HA; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., Khosa S; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., Wambre E; Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., Chichili GR; Astellas Pharma Global Development Inc., Northbrook, Illinois, USA.
Publikováno v:
Allergy [Allergy] 2024 Feb; Vol. 79 (2), pp. 456-470. Date of Electronic Publication: 2023 Nov 27.
Autor:
Calise J; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., DeBerg H; Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Garabatos N; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Khosa S; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Bajzik V; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Calderon LB; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Aldridge K; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Rosasco M; Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Ferslew BC; Astellas Pharma Global Development Inc, Northbrook, Ill., Zhu T; Astellas Pharma Global Development Inc, Northbrook, Ill., Smulders R; Astellas Pharma Global Development Inc, Northbrook, Ill., Wheatley LM; National Institute of Allergy and Infectious Diseases, Bethesda, Md., Laidlaw TM; Immune Tolerance Network, Benaroya Research Institute at Virginia Mason, Seattle, Wash; Department of Medicine, Harvard Medical School, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Qin T; Immune Tolerance Network, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Chichili GR; Astellas Pharma Global Development Inc, Northbrook, Ill., Adelman DC; Aimmune Therapeutics, Brisbane, Calif., Farrington M; Virginia Mason Medical Center, Seattle, Wash., Robinson D; Virginia Mason Medical Center, Seattle, Wash., Jeong D; Virginia Mason Medical Center, Seattle, Wash., Jones SM; Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Ark., Sanda S; Immune Tolerance Network, UCSF Diabetes Center & UCSF School of Medicine, San Francisco, Calif., Larson D; Immune Tolerance Network, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Kwok WW; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Baloh C; Immune Tolerance Network, Benaroya Research Institute at Virginia Mason, Seattle, Wash; Department of Medicine, Harvard Medical School, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass., Nepom GT; Immune Tolerance Network, Benaroya Research Institute at Virginia Mason, Seattle, Wash., Wambre E; Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Wash. Electronic address: ewambre@benaroyaresearch.org.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Jul; Vol. 152 (1), pp. 155-166.e9. Date of Electronic Publication: 2023 Mar 30.
Autor:
Wells MA; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Vendrov KC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Edin ML; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., Ferslew BC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Zha W; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Nguyen BK; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Church RJ; University of North Carolina Institute for Drug Safety Sciences, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Lih FB; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., DeGraff LM; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Barritt AS 4th; Division of Gastroenterology and Hepatology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Zeldin DC; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address: craig_lee@unc.edu.
Publikováno v:
Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2016 Sep; Vol. 125, pp. 19-29. Date of Electronic Publication: 2016 Jul 09.
Autor:
Lan K; Key laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy, Sichuan University , Chengdu 610041, China.; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Su M; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Xie G; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Ferslew BC; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599-7569, United States., Brouwer KL; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599-7569, United States., Rajani C; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Liu C; State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research , Tianjin 300193, China., Jia W; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2016 Jul 19; Vol. 88 (14), pp. 7041-8. Date of Electronic Publication: 2016 Jun 30.
Autor:
Ferslew BC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel Hill, NC, 27599, USA. bferslew@theravance.com.; Clinical Pharmacology and Drug Metabolism and Pharmacokinetics, Theravance Biopharma US, Inc., 901 Gateway Blvd, South San Francisco, CA, 94080, USA. bferslew@theravance.com., Xie G; Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA. GXie@cc.hawaii.edu., Johnston CK; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel Hill, NC, 27599, USA. curtis.k.johnston@gmail.com., Su M; Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA. MSu@cc.hawaii.edu., Stewart PW; Department of Biostatistics, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 3105G McGavran-Greenberg Hall, Chapel Hill, NC, 27599, USA. Paul_Stewart@unc.edu., Jia W; Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA. WJia@cc.hawaii.edu., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel Hill, NC, 27599, USA. kbrouwer@unc.edu., Barritt AS 4th; Division of Gastroenterology and Hepatology, UNC School of Medicine, University of North Carolina at Chapel Hill, 8004 Burnett Womack, CB #7584, Chapel Hill, NC, 27599-7584, USA. sid_barritt@med.unc.edu.
Publikováno v:
Digestive diseases and sciences [Dig Dis Sci] 2015 Nov; Vol. 60 (11), pp. 3318-28. Date of Electronic Publication: 2015 Jul 03.
Autor:
Ferslew BC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (B.C.F., K.K., K.L.R.B.) and Department of Pathology, UNC School of Medicine (A.S.B.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Köck K; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (B.C.F., K.K., K.L.R.B.) and Department of Pathology, UNC School of Medicine (A.S.B.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Bridges AS; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (B.C.F., K.K., K.L.R.B.) and Department of Pathology, UNC School of Medicine (A.S.B.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (B.C.F., K.K., K.L.R.B.) and Department of Pathology, UNC School of Medicine (A.S.B.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina kbrouwer@email.unc.edu.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2014 Sep; Vol. 42 (9), pp. 1567-74. Date of Electronic Publication: 2014 Jun 23.
Autor:
Ferslew BC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill., Brouwer KL
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2014 May; Vol. 139 (1), pp. 99-107. Date of Electronic Publication: 2014 Feb 22.
Autor:
Köck K; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (K.K., B.C.F., I.N., K.Y., K.L.R.B.), and Biostatistics Department, School of Public Health (P.W.St.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Pharmacy, Uppsala University, Uppsala, Sweden (I.N.); Center for Human Genome Variation, Duke University Medical Center, Durham, North Carolina (T.J.U.); and Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland (P.W.Sw.)., Ferslew BC, Netterberg I, Yang K, Urban TJ, Swaan PW, Stewart PW, Brouwer KL
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2014 Apr; Vol. 42 (4), pp. 665-74. Date of Electronic Publication: 2013 Oct 23.